Current problems with methicillin-resistant Staphylococcus aureus

Linezolid Alone and in Combination with Rifampicin Prevents Experimental Vascular Graft Infection Due to Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis

“…In the study presented here, rifampicin decreased the bacterial count sufficiently. But one of the disadvantages of rifampicin coated grafts is the well-known tendency to yield high MIC strains, especially against MRSA, and as topical usage accelerates this tendency, rifampicin should not be used alone as a prophylactic agent against such virulent strains [34,35].…”

Clonal dissemination of two MRSA strains in Germany

“…[6][7][8] methods. Results of typing indicate clonal dissemination of the most frequently isolated MRSA in western European countries [9][10][11][12]; MRSA isolated from infections in German hospitals were obviously different [1,13]. However from autumn 1992 until now we have observed clonal dissemination of two MRSA strains, one in the north and one in the south-west of Germany.…”

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Finland

“…In the UK, the first epidemic MRSA (UK EMRSA-1) seemed to be similar to the epidemic strain in eastern Australia (270). This strain was later superceded by a series of other MRSA strains (UK EMRSA-2-14), and in the 1990s by UK EMR-SA-15 and -16 (163,174). UK EMR-SA-15 and-16 gradually spread throughout the country, and they have also been identified elsewhere in Europe.…”